NRX Pharmaceuticals Chief Business Officer Randy Guggenheimer receives $3.6M in 2021
NRX Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: June 17, 2022
NRX Pharmaceuticals reported fiscal year 2021 executive compensation information on June 17, 2022.
In 2021, four executives at NRX Pharmaceuticals received on average a compensation package of $1.6M, a 102% increase compared to previous year.
Average pay of disclosed executives at NRX Pharmaceuticals
Randy Guggenheimer, Chief Business Officer, received $3.6M in total. 96% of Guggenheimer's compensation, or $3.4M, was in option awards. Guggenheimer also received $144K in salary.
Alessandra Daigneault, General Counsel, received a compensation package of $2.3M. 77% of the compensation package, or $1.8M, was in option awards.
Jonathan Javitt, Chief Executive Officer, earned $377K in 2021, a 39% decrease compared to previous year.
Robert Besthof, Chief Executive Officer, received $264K in 2021, which decreases by 73% compared to 2020.
Related executives
You may also like
Source: SEC filing on June 17, 2022.